Salicylate-Aspirin Interaction and Thrombosis Prevention Trials

C de Castellarnau; C Cerletti; E Dejana; F Galletti; R Latini; M Livio; G de Gaetano

doi:10.1055/s-0038-1650191

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1981; 45(03): 294
DOI: 10.1055/s-0038-1650191

Letter to the Editor

Schattauer GmbH Stuttgart

Salicylate-Aspirin Interaction and Thrombosis Prevention Trials

C de Castellarnau

Istituto di Ricerche Farmacologiche, “Mario Negri”, Via Eritrea, 62, 20157 Milan, Italy

,

C Cerletti

Istituto di Ricerche Farmacologiche, “Mario Negri”, Via Eritrea, 62, 20157 Milan, Italy

,

E Dejana

Istituto di Ricerche Farmacologiche, “Mario Negri”, Via Eritrea, 62, 20157 Milan, Italy

,

F Galletti

Istituto di Ricerche Farmacologiche, “Mario Negri”, Via Eritrea, 62, 20157 Milan, Italy

,

R Latini

Istituto di Ricerche Farmacologiche, “Mario Negri”, Via Eritrea, 62, 20157 Milan, Italy

,

M Livio

Istituto di Ricerche Farmacologiche, “Mario Negri”, Via Eritrea, 62, 20157 Milan, Italy

,

G de Gaetano

Istituto di Ricerche Farmacologiche, “Mario Negri”, Via Eritrea, 62, 20157 Milan, Italy

› Institutsangaben

Abstract

als PDF herunterladen

PDF (210 kb)

Referenzen

References
1 Moncada S, Vane JR. Prostacyclin, platelet aggregation and thrombosis. In: de GaetanoG, Garattini S. eds. Platelets: A Multidisciplinary Approach. New York: Raven Press; 1978: 239-259
2 Burch JW, Baezinger NL, Stanford N, Majerus PW. Sensitivity of fatty acid cyclooxygenase from human aorta to acetylation by aspirin. Proc Natl Acad Sci 1978; 75: 5181-5184
3 Villa S, Livio M, de GaetanoG. The inhibitory effect of aspirin on platelet and vascular prostaglandin in rats cannot be completely dissociated. Br J Haematol 1979; 42: 425-431
4 Masotti G, Galanti G, Poggesi L, Abbate R, Neri Serneri GG. Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet 1979; 02: 1213-1217
5 Editorial. Aspirin after myocardial infarction. Lancet 1980; 01: 1172-1173
6 Vargaftig BB. The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines. Eur J Pharmacol 1978; 50: 231-241
7 Merino J, Livio M, Rajtar G, de GaetanoG. Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation. Biochem Pharmacol 1980; 29: 1093-1096
8 Ali M, McDonald JW D. Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity. Prostaglandins and Medicine 1979; 03: 327-332
9 Rowland M, Riegelman S, Harris PA, Sholkoff SD. Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci 1972; 61: 379-385
10 Buchanan MR, Dejana E, Cazenave JP, Richardson M, Mustard JF, Hirsch J. Differences in inhibition of PGI2 production by aspirin in rabbit artery and vein segments. Thromb Res 1980; 20: 447-460
11 Lewy RI, Smith JB, Silver MJ, Saia J, Walinsky P, Wiener L. Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal’s angina. Prostaglandins and Medicine 1979; 05: 243-248
12 Cotty VF, Ederma HM. Method for the direct measurement of acetylsalicylic acid in human blood. J Pharm Sci 1966; 55: 837-839